UY29435A1 - DERIVATIVES OF 5H-BENZOCICLOHEPTENO, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY. - Google Patents
DERIVATIVES OF 5H-BENZOCICLOHEPTENO, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY.Info
- Publication number
- UY29435A1 UY29435A1 UY29435A UY29435A UY29435A1 UY 29435 A1 UY29435 A1 UY 29435A1 UY 29435 A UY29435 A UY 29435A UY 29435 A UY29435 A UY 29435A UY 29435 A1 UY29435 A1 UY 29435A1
- Authority
- UY
- Uruguay
- Prior art keywords
- preparation
- derivatives
- benzociclohepteno
- inflammatory
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
La invención se refiere a derivados de 5H-benzociclohepteno polisustituidos de la fórmula (I) a procedimientos para su preparación y a su uso como antiinflamatorios.The invention relates to polysubstituted 5H-benzocycloheptene derivatives of the formula (I) to methods for their preparation and their use as anti-inflammatories.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005014090A DE102005014090A1 (en) | 2005-03-22 | 2005-03-22 | 5H-Benzocycloheptender derivatives, process for their preparation and their use as anti-inflammatory agents |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29435A1 true UY29435A1 (en) | 2006-10-02 |
Family
ID=36589218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29435A UY29435A1 (en) | 2005-03-22 | 2006-03-21 | DERIVATIVES OF 5H-BENZOCICLOHEPTENO, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1863765A1 (en) |
JP (1) | JP2008534462A (en) |
CN (1) | CN101146773A (en) |
AR (1) | AR053189A1 (en) |
CA (1) | CA2598969A1 (en) |
DE (1) | DE102005014090A1 (en) |
DO (1) | DOP2006000065A (en) |
GT (1) | GT200600124A (en) |
PA (1) | PA8666801A1 (en) |
PE (1) | PE20061350A1 (en) |
TW (1) | TW200700389A (en) |
UY (1) | UY29435A1 (en) |
WO (1) | WO2006100099A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE057892T2 (en) * | 2016-02-15 | 2022-06-28 | Sanofi Sa | Processes and intermediates for the preparation of novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds |
CN107118173B (en) * | 2017-07-12 | 2019-10-29 | 阿里生物新材料(常州)有限公司 | A kind of cycloheptatriene and oxazine compound and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8402275A (en) * | 1974-08-26 | 1977-02-17 | Takeda Chemical Industries Ltd | Benzocycloheptene derivatives |
PT87487B (en) * | 1987-05-15 | 1992-09-30 | Schering Corp | PROCESS FOR THE PREPARATION OF NAFTALENE, BENZOXEPIN, BENZAZEPINE AND BENZOCYCLOHEPTEN DERIVATIVES |
WO1989000570A1 (en) * | 1987-07-16 | 1989-01-26 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New diazols |
WO1999005107A1 (en) * | 1997-07-25 | 1999-02-04 | Smithkline Beecham Corporation | Vitronectin receptor antagonist |
BRPI0407304A (en) * | 2003-02-07 | 2006-01-10 | Warner Lambert Co | Antibacterial agents |
-
2005
- 2005-03-22 DE DE102005014090A patent/DE102005014090A1/en not_active Withdrawn
-
2006
- 2006-03-20 EP EP06723721A patent/EP1863765A1/en not_active Withdrawn
- 2006-03-20 CN CNA2006800096370A patent/CN101146773A/en active Pending
- 2006-03-20 JP JP2008502339A patent/JP2008534462A/en active Pending
- 2006-03-20 WO PCT/EP2006/002742 patent/WO2006100099A1/en not_active Application Discontinuation
- 2006-03-20 CA CA002598969A patent/CA2598969A1/en not_active Abandoned
- 2006-03-21 DO DO2006000065A patent/DOP2006000065A/en unknown
- 2006-03-21 GT GT200600124A patent/GT200600124A/en unknown
- 2006-03-21 PE PE2006000307A patent/PE20061350A1/en not_active Application Discontinuation
- 2006-03-21 UY UY29435A patent/UY29435A1/en not_active Application Discontinuation
- 2006-03-21 PA PA20068666801A patent/PA8666801A1/en unknown
- 2006-03-22 TW TW095109925A patent/TW200700389A/en unknown
- 2006-03-22 AR ARP060101120A patent/AR053189A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006100099A1 (en) | 2006-09-28 |
AR053189A1 (en) | 2007-04-25 |
PE20061350A1 (en) | 2006-12-20 |
CA2598969A1 (en) | 2006-09-28 |
GT200600124A (en) | 2007-01-03 |
PA8666801A1 (en) | 2006-09-22 |
CN101146773A (en) | 2008-03-19 |
EP1863765A1 (en) | 2007-12-12 |
TW200700389A (en) | 2007-01-01 |
DE102005014090A1 (en) | 2006-09-28 |
JP2008534462A (en) | 2008-08-28 |
DOP2006000065A (en) | 2006-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066539A (en) | DERIVATIVES 1-AMINO-2-OXI SUBSTITUTED FOR TETRAHYDRONAFTALENE, PROCEDURE FOR PREPARATION AND USE AS AN ANTI-INFLAMMATORY | |
ECSP077271A (en) | PIRIMIDINE DERIVATIVES | |
ECSP077259A (en) | PIRIMIDINE DERIVATIVES | |
PA8657801A1 (en) | TRICYCLE AMINALCOHOLES, PROCEDURES FOR THEIR PREPARATION | |
ECSP088740A (en) | TETRAHYDRONAFTALINE DERIVATIVES, PROCEDURES TO PREPARE THEM AND THEIR USE AS ANTI-INFLAMMATORIES | |
DOP2011000171A (en) | ORGANIC COMPOUNDS | |
GT200600081A (en) | ACETYLENE DERIVATIVES | |
ECSP066540A (en) | PENTANOLS TRANSPOSED, A METHOD FOR PREPARING THEM AND THEIR USE AS ANTI-INFLAMMATORY | |
UY29213A1 (en) | DERIVATIVES OF QUINOLIN AND ISOQUINOLINE 5-SUSTITIUED, A PROCEDURE FOR THEIR PREPARATION AND ITS USE AS INFLAMMATION INHIBITORS | |
UY29434A1 (en) | DERIVATIVES OF TETRAHYDRONAFTALINE, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS INFLAMMATION INHIBITORS | |
PA8644701A1 (en) | DERIVATIVES OF ALQUILIDEN-TETRAHIDRONAFTALENO, PROCEDURE FOR ITS PREPARATION AND ITS USE AS ANTI-INFLAMMATORIES | |
GT200600153A (en) | TETRAHYDRONAFTALINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY. | |
ECSP077979A (en) | AMPA RECEIVER POTENTIATORS | |
UY29435A1 (en) | DERIVATIVES OF 5H-BENZOCICLOHEPTENO, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY. | |
DK1893597T3 (en) | AMPA receptor potentiators | |
UY30235A1 (en) | INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE | |
UY30236A1 (en) | INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE | |
UY30237A1 (en) | INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE | |
UY29482A1 (en) | TETRAHYDRONAFTALINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY. | |
UY28584A1 (en) | DERIVATIVES OF TETRAHYDRONAFTALENE, PROCEDURE FOR PREPARATION AND USE AS AN ANTI-INFLAMMATORY | |
CU23569A3 (en) | DERIVATIVES 1-AMINO-2-OXI SUBSTITUTED FOR TETRAHYDRONAFTALENE, PROCEDURE FOR PRODUCTION AND USE AS AN ANTI-INFLAMMATORY | |
DOP2006000064A (en) | TETRAHYDRONAFTALINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS INFLAMMATION INHIBITORS | |
UY29309A1 (en) | TRICYCLIC AMINOALCOHOLES, PROCEDURES FOR PREPARATION AND USE AS INFLAMMATION INHIBITORS | |
UY28907A1 (en) | CHROMANOL DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION AND ITS USE AS INFLAMMATION INHIBITORS. | |
CU23350B7 (en) | 2TIO-3,5DICYANO-4-FENIL-6-AMINOPIRIDINAS REPLACED AND ITS USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160810 |